ACPA Raises Concerns Over Lack of Transparency in Proposed Ban on Aesthetic Injections by ACP
The Alberta Cosmetic Pharmacist Association (ACPA) has issued a press release, highlighting concerns over the lack of transparency surrounding the proposed ban on aesthetic injections by the Alberta College of Pharmacy (ACP). The press release emphasizes the importance of preserving innovation in pharmacy practice and calls for a more inclusive and collaborative approach that considers patient access and professional growth.
The ACPA, led by Dr. Kamal Alhallak, President of the association, expresses concern that the ACP buried the proposed ban within a 55-page document without explicitly highlighting the issue. This lack of transparency has resulted in limited awareness among pharmacists, hindering their ability to provide informed feedback during the consultation period.
In response to these concerns, the ACPA has launched a petition, urging pharmacists and stakeholders to stand together against the proposed ban. The petition aims to raise awareness about the potential impact on patient access, professional growth, and the future of pharmacy practice in Alberta. By mobilizing their collective voices, the ACPA hopes to encourage the Alberta College of Pharmacy to reconsider its decision and foster a more collaborative approach.
The press release calls on the public, media outlets, and healthcare stakeholders to support the ACPA’s efforts in preserving innovation within pharmacy practice. It emphasizes the need for open dialogue, transparency, and a comprehensive understanding of the implications of the proposed ban.